Dr. Jim Lavery is an Associate Scientist at the Li Ka Shing Knowledge Institute of St. Michael’s Hospital. He is also an Associate Professor in the Dalla Lana School of Public Health, Institute of Medical Science, and Joint Centre for Bioethics at the University of Toronto.
His research focuses on how improved understanding of the interests of stakeholders in global health and global development research—including funders, implementation partners, regulators, researchers, research institutions, and host communities—can improve the implementation and impact of new health interventions. Jim was the co-principal investigator of the Ethical, Social and Cultural (ESC) Program for the Bill & Melinda Gates Foundation’s Global Health and Global Development programs from 2005-2015. He is currently funded by the Gates Foundation to lead the development of a “Learning Platform” to help research funders and their implementation partners improve their strategies for engaging with stakeholders to improve the delivery and implementation of their research investments.
He has served on the Canadian Federal Interagency Advisory Panel on Research Ethics and is currently a member of numerous advisory committees, including the Data Safety and Monitoring Board for the U.S. Centers for Disease Control and Prevention’s STRIVE Ebola Vaccine trial in Sierra Leone, the Executive Advisory Committee for the Institute for Global Health Equity & Innovation at the University of Toronto, the Regulatory and Ethics Working Group for the Global Alliance on Genomics and Health, the Bioethics Advisory Panel, and Independent Review Panel for Data Access Requests, for Pfizer, Inc.